STAT NEWS

PharmedOUT in STAT News:

• January 19, 2021 Family medicine residents don’t interact with pharma as much as they once did By Ed Silverman

• February 27, 2020 Health care conference about conflicts of interest has a conflict itself, say critics who won’t attend By Ed Silverman

• June 11, 2019 Industry-funded attacks on the CDC's opioid prescribing guideline are eroding public health By Ben Goodwin, Judy Butler, and Adriane Fugh-Berman

• May 30, 2019: The chronic-pain quandary: Amid a reckoning over opioids, a doctor crusades for caution in cutting back By Andrew Joseph

• April 9, 2019: ‘We owe much to the Sackler family’: How gifts to a top medical school advanced the interests of Purdue Pharma By Andrew Joseph

• October 11, 2018: Pfizer pays $700,000 to settle charges over misleading copay coupons By Ed Silverman

• October 2, 2018: Caregivers or Marketers? Nurses paid by drug companies facing scrutiny as whistleblower lawsuits mount By Ed Silverman and Karen Weintraub

• June 18, 2018: Donations of $4,500 overdose antidote were PR gold for drug maker — but some kits were close to expiring By Max Blau

• April 23, 2018: How a patient advocacy group is used to promote an Insys drug and other fentanyl meds By Ed Silverman

• March 9, 2018: McCaskill plans a bill to force pharma to disclose payments to nonprofits and advocacy groups By Ed Silverman

• June 28, 2017: The FDA may move to shorten that grim list of side effects in every drug ad. Advertising execs can’t wait By Megan Thielking

• September 30, 2016: A potent painkiller, and the drug maker's marketing, are faulted in a woman's death By David Armstrong

• July 6, 2016: Pfizer agrees to opioid marketing deal to escape a lawsuit by Chicago By Ed Silverman